Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy With or Without Sargramostim in Treating Patients With Metastatic Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00062153   Information provided by National Cancer Institute (NCI)
First Received: June 5, 2003   Last Updated: July 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
fowlpox-PSA-TRICOM vaccine
sargramostim
vaccinia-PSA-TRICOM vaccine
Additional drug interventions recognized in this trial
Metronidazole
More general drug interventions related to this trial
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services